Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Lymphoma, Large B-Cell, Diffuse 53Lymphoma, Non-Hodgkin 33Leukemia 33Burkitt Lymphoma 33Lymphoma, Mantle-Cell 20Lymphoma, Follicular 19Recurrence 13Lymphoma, B-Cell 13Hodgkin Disease 13Neoplasms 11Lymphoma, Large-Cell, Anaplastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Sarcoma 9Neuroblastoma 8Multiple Myeloma 8Medulloblastoma 8Lymphoma, T-Cell, Peripheral 8Lymphoma, T-Cell 7Central Nervous System Neoplasms 7Rhabdomyosarcoma 6Leukemia, Biphenotypic, Acute 6Lymphoma, B-Cell, Marginal Zone 5Wilms Tumor 4Waldenstrom Macroglobulinemia 4Sarcoma, Ewing 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large-Cell, Immunoblastic 4

Interventions

Valganciclovir 2Rituximab 2tocilizumab 1human papillomavirus vaccine, L1 type 16, 18 1Zidovudine 1Watchful Waiting 1Vincristine 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Sugars 1Rapid Diagnostic Tests 1Prednisone 1Observation 1Methotrexate 1Maltose 1Light Coagulation 1Leucovorin 1Laser Therapy 1Interviews as Topic 1Interferon-alpha 1Imiquimod 1Fluorouracil 1Filgrastim 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Electrocoagulation 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Acquired Immunodeficiency Syndrome × Vincristine × Clear all
NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
68 enrolled 24 charts
Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡